Protein Barcoding: Multiplexed Screening for High-efficiency Pre-clinical Studies 

Accelerate decisions and reduce costs with 24× the analytical power 

Protein barcoding makes the pre-clinical drug development process more efficient and cost-effective through multiplexed protein screening, to accelerate the path to first in human trials.

This infographic highlights how multiplexing with Next-Gen Protein Sequencing™ and the Quantum-Si Barcoding Kit is a standout solution for pre-clinical researchers seeking a highly efficient solution.

Key takeaways from this infographic include:

• Direct protein detection: Quantify expression and differentiate functional performance of proteins 
• Multiplexing power: Test multiple candidates in a single-model organism with up to 24× the power of single-plex analysis
• Cost-effectiveness: Consolidate testing to reduce pre-clinical cost in vivo and in vitro
• Analytical validity: Resolve expression changes across a 120-fold dynamic range (half chip) or 240-fold (full chip).
• Diverse applications in protein engineering: Validate CRISPR gene editing, track protein localization, explore protein-protein interaction